| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2013 | CN102048727B Application of formononetin in preparing of medicament for restricting angiogenesis |
| 04/17/2013 | CN102038641B Preparation method of liposome medicine with outer layer modified by hydrophilic polymer |
| 04/17/2013 | CN102030744B Iloperidone crystal and preparation method and medicinal composition thereof |
| 04/17/2013 | CN102020625B High-purity lubiprostone, preparation method and application thereof |
| 04/17/2013 | CN101984974B Preparation method of pharmaceutical composition for treating type II diabetes |
| 04/17/2013 | CN101973979B Antibacterial compound and application thereof |
| 04/17/2013 | CN101973935B Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 04/17/2013 | CN101967105B Beta-hydroxy protected didecyl quaternary ammonium salt with anticancer activity and preparation method thereof |
| 04/17/2013 | CN101952283B Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 04/17/2013 | CN101939013B Use of composition for preparing medicine for treating fibromyalgia syndrome and pain from vascular smooth muscle spasm |
| 04/17/2013 | CN101926813B Veterinary compound anti-parasitic injection and preparation method thereof |
| 04/17/2013 | CN101925584B Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis |
| 04/17/2013 | CN101921711B Alternarlactam and preparation method and application thereof |
| 04/17/2013 | CN101903389B Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 04/17/2013 | CN101903380B 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 04/17/2013 | CN101899048B Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester |
| 04/17/2013 | CN101898966B Piperazine ring-containing Artemisia rupestris L. keto ester derivative as well as preparation method thereof |
| 04/17/2013 | CN101857540B Method for producing adipic acid, hexamethylenediamine hydrochloride and polyhexamethylene (di)guanidine chloride from nylon-66 through depolymerization |
| 04/17/2013 | CN101837004B Application of dioscin in preparation of liver-protecting pharmaceutical preparation |
| 04/17/2013 | CN101822646B Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof |
| 04/17/2013 | CN101821392B RNA sequence motifs in the context of defined inter-nucleotide linkages inducing specific immune modulatory profiles |
| 04/17/2013 | CN101811956B Preparation method of trans-crocetin |
| 04/17/2013 | CN101810715B New application of fructus evodiae and extracts and compounds thereof |
| 04/17/2013 | CN101766640B Preparation for panaxoside-Rd aqueous solution of propylene glycol and new application thereof in inflammation resistance, immune suppression and organ transplant rejection resistance |
| 04/17/2013 | CN101754765B Emulsion compositions |
| 04/17/2013 | CN101747148B Melt crystallization preparation technology of DC (direct compression) grade xylitol |
| 04/17/2013 | CN101744792B Fluticasone propionate and salmeterol xinafoate compound dry powder inhalation and preparation technology thereof |
| 04/17/2013 | CN101721394B Granisetron and/or hydrochloride patch thereof |
| 04/17/2013 | CN101679437B Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 04/17/2013 | CN101679411B MAPK/ERK kinase inhibitors |
| 04/17/2013 | CN101678036B Novel active ingredient in cicatrization and use thereof |
| 04/17/2013 | CN101678010B A composition comprising (R)-spiro[l- azabicyclo[2.2.2]octane-3,2'(3'h) -furo[2,3 -b]pyridine (azd0328) and its use in the treatment of alzheimer's disease, ADHD or cognitive dysfunction |
| 04/17/2013 | CN101671376B Alkannin acetyl glucose and preparation method and application thereof |
| 04/17/2013 | CN101653431B Oral mucosa medicament slow release preparation for treating oral periodontal disease and preparation thereof |
| 04/17/2013 | CN101652363B Thiazolyl compounds useful as kinase inhibitors |
| 04/17/2013 | CN101646342B Disinfectant |
| 04/17/2013 | CN101623295B Medicine for treating bladder neoplasms |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101583362B Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 04/17/2013 | CN101553483B 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/17/2013 | CN101548968B Application of chroman compound HEF-19 in preparing intestinal canal smooth muscle antispastic and antidiarrhoeal |
| 04/17/2013 | CN101541299B Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 04/17/2013 | CN101522703B Bile acid derivatives and its uses in the prevention or treatment of fxr-mediated diseases or conditions |
| 04/17/2013 | CN101501036B Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 04/17/2013 | CN101480403B Medicament composition and preparation method thereof |
| 04/17/2013 | CN101472576B N-hydroxylsulfonamide derivatives as physiologically useful nitroxyl donors |
| 04/17/2013 | CN101456824B Alpha-amido-N-substituted amide compounds, medicament composition containing the same and use thereof |
| 04/17/2013 | CN101389622B Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 04/17/2013 | CN101365487B Method for treating joint damage |
| 04/17/2013 | CN101361754B Use of rare-earth element salt or pharmaceutical composition thereof in preparing medicine for treating or preventing diabetes and adiposis |
| 04/17/2013 | CN101360485B Hydrophilic vehicle-based dual controlled release matrix system |
| 04/17/2013 | CN101326160B Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 04/17/2013 | CN101316597B Aminopyrimidines useful as kinase inhibitors |
| 04/17/2013 | CN101239929B Trichostatin A derivatives, preparation method and use thereof |
| 04/17/2013 | CN101232902B Noninvasive drug delivery system to posterior part tissue of eye by using solid composition |
| 04/17/2013 | CN101194922B Acesodyne medicament dropping pills and method for preparing the same |
| 04/17/2013 | CN101171012B Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 04/17/2013 | CN101168047B Composition with radiation-proof, anti-oxidation and DNA-protection effects and use |
| 04/17/2013 | CN101166732B Cyanopyridine derivative and use thereof as medicine |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/17/2013 | CN101119725B Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 04/17/2013 | CN101119706B Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a chelating agent |
| 04/17/2013 | CN101027288B HIV inhibiting 5-substituted pyrimidines |
| 04/17/2013 | CN101006092B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same |
| 04/16/2013 | USRE44159 Composition for contraception |
| 04/16/2013 | US8420863 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 04/16/2013 | US8420835 Process for producing carnosol from carnosic acid |
| 04/16/2013 | US8420830 Macrocyclic factor VIIa inhibitors useful as anticoagulants |
| 04/16/2013 | US8420828 Inhibitors |
| 04/16/2013 | US8420827 Thiazole derivatives |
| 04/16/2013 | US8420825 Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs |
| 04/16/2013 | US8420823 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/16/2013 | US8420822 Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles |
| 04/16/2013 | US8420810 Bicyclic heterocyclic compound |
| 04/16/2013 | US8420806 Process for the crystallisation of cefadroxil monohydrate |
| 04/16/2013 | US8420799 Therapeutic compositions |
| 04/16/2013 | US8420780 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 04/16/2013 | US8420698 Histone deacetylase inhibitors |
| 04/16/2013 | US8420697 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom |
| 04/16/2013 | US8420696 Use of low-dose ladostigil for neuroprotection |
| 04/16/2013 | US8420695 Inhibitors of janus kinases |
| 04/16/2013 | US8420694 Pyrrolidin-2-one derivatives as androgen receptor modulator |
| 04/16/2013 | US8420693 Prevent replication or infection from virus; antiproliferative agent; screening analysis |
| 04/16/2013 | US8420692 Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents |
| 04/16/2013 | US8420691 Combination of selected analgesics and COX-II inhibitors |
| 04/16/2013 | US8420690 Inhibitors of Akt activity |
| 04/16/2013 | US8420689 Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/16/2013 | US8420688 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| 04/16/2013 | US8420687 Pharmaceutical composition |
| 04/16/2013 | US8420686 Linked diimidazole antivirals |
| 04/16/2013 | US8420685 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 04/16/2013 | US8420684 Inhibitors of glutaminyl cyclase |
| 04/16/2013 | US8420683 5 substituted hydantoins |
| 04/16/2013 | US8420682 N-phenylacetamide derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 04/16/2013 | US8420681 Dioxo-imidazolidine derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 04/16/2013 | US8420680 NMDA receptor antagonists for neuroprotection |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420678 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 04/16/2013 | US8420677 Use of 3,3′-diindolylmethane |